A meta-analysis found that soy products, especially tofu and natto, were associated with lower risks of type 2 diabetes and cardiovascular events, but this risk reduction did not apply to miso, partly due to its higher sodium content.
Notes on verification
Confirmed by a peer-reviewed meta-analysis (MDPI Nutrients 2023) and corroborating secondary coverage (PMC, News-Medical), consistent findings across sources.
Sources
- Is Miso Soup Good for You? Benefits, Nutrition & Risks - WebMD (webmd.com)
- https://www.mdpi.com/2072-6643/15/6/1358 (mdpi.com)
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058927/ (ncbi.nlm.nih.gov)
- https://www.news-medical.net/news/20230315/How-does-soy-consumption-affect-the-risk-of-type-2-diabetes-and-cardiovascular-diseases.aspx (news-medical.net)